Form 4 for SRPT Sarepta Therapeutics, Inc.
Accepted 2025-03-13 00:00:00 ET · period of report 2025-03-12 · accession 0000950170-25-039037 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-13 | 2025-03-12 | SRPT | Nicaise Claude | Dir | S - Sale+OE | $99.64 | -2,491 | 27.8K | -8% | -$248.2K |
| D | 2025-03-13 | 2025-03-12 | SRPT | Nicaise Claude | Dir | M - OptEx | $25.18 | +9,746 | 30.3K | +47% | +$245.4K |
| D | 2025-03-13 | 2025-03-12 | SRPT | Nicaise Claude | Dir | M - OptEx | $0.00 | -9,746 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-12 | S | D | 2,491 | $99.64 | 27,812 | D | — | — | (F1) The shares were sold to cover the exercise price relating to the exercise of stock options to purchase shares, which are scheduled to expire in 2025. (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.64 and $99.87, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| 2 | Common | Common Stock | 2025-03-12 | M | A | 9,746 | $25.18 | 30,303 | D | — | — | |
| 3 | Derivative | Stock Options (right to buy) | 2025-03-12 | M | D | 9,746 | $0.00 | 0 | D | $25.18 · 2016-06-02 to 2025-06-02 | 9,746 Common Stock |